Cytogenetics is the study of chromosomal structure, location and function in cells. It includes the study of chromosome number and appearance (karyotyping), the physical location of genes on ...

New Evidence Links Microplastics with Chronic Disease Places with higher concentrations of microplastics see higher rates of hypertension, diabetes, stroke and other noncommunicable diseases Date ...

How Does Polycythemia Vera Advance? Polycythemia vera affects your bone marrow, the spongy tissue in the center of your bones that makes blood cells. The disease causes your bone marrow to make ...

Chronic Myeloid Leukemia (CML) is a cancer of the white blood cells, resulting in the overproduction of unfit cells called blasts. This cancer is driven by the Philadelphia chromosome and the BCR-ABL1 ...

Children in the United States are increasingly suffering from persistent or severe health conditions, many of which are preventable and could follow them into adulthood, according to new research. The ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Methods: We report a case of a 28-year-old female with e19a2-positive CML. The patient exhibited poor response and tolerance to dasatinib. After 6 months, she achieved partial cytogenetic response ...

Chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) are two different types of leukemia. Both conditions affect white blood cells. CML affects a type of white blood cell called ...

The Trump administration has canceled funding for an ongoing 30-year, nationwide study tracking patients with prediabetes and diabetes, researchers said, at a time when top officials have ...

Patients achieving a cytogenetic response within 12 months ... Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology ...

Table 1. Cytogenetic and molecular response rates of large clinical trials testing first-line high-dose imatinib in chronic-phase chronic myeloid leukemia. Study (year) Trial Response (%) Ref.